Target intelligence / Profile preview

Delftia acidovorans (D. acidovorans)

Target
D. acidovorans
Molecular classification
Bacterium (6, 14), Gram-negative bacillus (4, 8, 10), Other
01

Overview

Delftia acidovorans is a Gram-negative, non-fermenting aerobic bacillus that belongs to the Comamonadaceae family, previously classified under the genera Pseudomonas and Comamonas (1, 6). While it is primarily an environmental saprophyte found in soil and water, it has emerged as an opportunistic human pathogen capable of causing serious infections such as bacteremia, infective endocarditis, and pneumonia, particularly in immunocompromised individuals or those with indwelling medical devices (2, 4). A unique biological feature of this organism is its ability to biomineralize gold; it secretes the non-ribosomal peptide delftibactin, which protects the bacterium by precipitating toxic gold ions into harmless metallic gold nuggets (6, 13). Clinically, D. acidovorans is notable for its intrinsic resistance to aminoglycosides, which complicates empirical treatment strategies for Gram-negative infections (2, 8). Effective therapeutic options generally include carbapenems, piperacillin-tazobactam, and trimethoprim-sulfamethoxazole, though susceptibility can vary among clinical isolates (1, 3, 15). (1) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214660/ (2) https://pubmed.ncbi.nlm.nih.gov/22130722/ (3) https://microbiologyopen.onlinelibrary.wiley.com/doi/full/10.1002/mbo3.1311 (4) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629471/ (6) https://en.wikipedia.org/wiki/Delftia_acidovorans (8) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444101/ (13) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253457/ (15) https://pubmed.ncbi.nlm.nih.gov/35835222/

Other names
Comamonas acidovorans (6, 10, 14)Pseudomonas acidovorans (6, 10, 14)Pseudomonas indoloxidans (6, 10)Pseudomonas desmolytica (6, 10)
02

Mechanism of action

Antibacterial agents targeting this organism act through various mechanisms: inhibition of bacterial cell wall synthesis (beta-lactams), inhibition of protein synthesis (tigecycline), inhibition of folate metabolism (trimethoprim-sulfamethoxazole), or inhibition of DNA gyrase/topoisomerase (fluoroquinolones) (1, 2, 8).

03

Biological functions

Biomineralization (specifically gold precipitation) (6, 7)Biodegradation of organic pollutants (9)Biofilm formation (2, 8)Xenobiotic metabolism (9)Inhibition of Staphylococcus epidermidis growth via ROS production (11, 13)
04

Disease associations

Infection (3, 14)Bacteremia (2, 5, 8)Infective endocarditis (2, 10)Pneumonia (4, 7)Catheter-associated bloodstream infection (4, 8, 10)
05

Safety considerations

Intrinsic resistance to all aminoglycosides (2, 4, 8)Biofilm-mediated persistence on medical devices (2, 15)Potential for multidrug resistance development (8, 9)High mortality rates in patients with underlying malignancies (3, 5)
06

Interacting drugs

Piperacillin-tazobactam (1, 8)

7 more in the full profile.

07

Biomarkers

16S rRNA gene sequencing (8)MALDI-TOF mass spectrometry identification (8)Positive orange indole biochemical reaction (4, 6, 8)

Beyond the preview

Go deeper on Delftia acidovorans (D. acidovorans).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delftia acidovorans (D. acidovorans).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call